Drug costs 'have to be secret' under new pricing system


Drug prices agreed under the government’s proposed new pricing system would have to remain secret if drug companies are to buy into it, a senior figure in the pharmaceutical industry has warned.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here